JBSS SANFILIPPO JOHN B & SON INC
Sugar & Confectionery Products · Nasdaq · SEC CIK 880117 · Fiscal year ends 06/28
Financial factors as of 2026-09-24 (2026Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY3.1%
TTM net income YoY-14.6%
TTM EPS YoY-14.9%
Revenue 3-yr CAGR5.9%
Net income 3-yr CAGR-4.6%
Margins
Gross margin17.7%
Operating margin7.0%
Net margin4.8%
FCF margin2.6%
EBITDA margin9.4%
Returns
ROE15.4%
ROA8.9%
ROIC (approx.)15.0%
Asset turnover1.83x
Leverage & solvency
Liabilities / assets44.9%
Debt / equity0.13x
Current ratio1.96x
Interest coverage38.30x
Cash quality & payout
Operating cash flow / net income1.81x
Accruals ratio-7.2%
Payout ratio93.4%
Capex / revenue6.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-25 | FY20252025-06-26 | FY20242024-06-27 | FY20232023-06-29 | FY20222022-06-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.18B | $1.11B | $1.07B | $999.69M | $955.87M |
| Cost of revenue | $964.49M | $903.77M | $852.64M | $788.05M | $756.24M |
| Gross profit | $211.18M | $203.47M | $214.14M | $211.63M | $199.63M |
| R&D expense | $3.33M | $3.49M | $3.62M | $3.36M | $2.83M |
| SG&A expense | $43.04M | $39.83M | $48.48M | $44.60M | $37.66M |
| Operating income | $89.20M | $84.71M | $85.19M | $90.22M | $87.44M |
| Interest expense | $2.43M | $3.55M | $2.55M | $2.16M | $1.92M |
| Pretax income | $82.97M | $77.86M | $79.94M | $85.35M | $81.70M |
| Income tax | $21.04M | $18.93M | $19.69M | $22.49M | $19.91M |
| Net income | $61.93M | $58.93M | $60.25M | $62.86M | $61.79M |
| EBITDA | $117.40M | $111.64M | $109.77M | $110.74M | $105.72M |
| EPS (basic) | 5.29 | 5.06 | 5.19 | 5.43 | 5.36 |
| EPS (diluted) | 5.26 | 5.03 | 5.15 | 5.40 | 5.33 |
| Dividends declared per share | 4.00 | 2.10 | 3.00 | 4.75 | 3.00 |
| Weighted avg. shares (diluted) | 11.78M | 11.72M | 11.69M | 11.64M | 11.59M |
| Balance sheet | |||||
| Cash & equivalents | $1.15M | $585,000 | $484,000 | $1.95M | $415,000 |
| Receivables | $84.31M | $76.66M | $84.96M | $72.73M | $69.61M |
| Inventory | $245.83M | $254.60M | $196.56M | $172.94M | $204.85M |
| Current assets | $349.31M | $346.42M | $294.08M | $254.43M | $283.16M |
| PP&E, net | $255.97M | $178.22M | $165.09M | $135.48M | $132.57M |
| Goodwill | $11.75M | $11.75M | $11.75M | $11.75M | $9.65M |
| Intangibles | $3.39M | $4.43M | $5.82M | $6.66M | $8.06M |
| Total assets | $658.58M | $597.60M | $515.58M | $425.29M | $447.26M |
| Current liabilities | $167.93M | $156.05M | $125.94M | $85.69M | $122.76M |
| Short-term debt | $6.05M | $941,000 | $737,000 | $672,000 | $3.15M |
| Long-term debt | $43.57M | $14.56M | $6.37M | $7.10M | $7.77M |
| Total debt | $49.62M | $15.51M | $7.10M | $7.77M | $10.92M |
| Total liabilities | $278.63M | $236.91M | $192.96M | $133.08M | $168.44M |
| Shareholders' equity | $379.95M | $360.70M | $322.61M | $292.21M | $278.82M |
| Net debt | $48.47M | $14.92M | $6.62M | $5.83M | $10.51M |
| Cash flow statement | |||||
| Operating cash flow | $123.84M | $30.55M | $101.67M | $124.66M | $19.60M |
| Capital expenditure | $88.09M | $50.71M | $28.31M | $20.73M | $17.75M |
| Free cash flow | $35.75M | -$20.17M | $73.36M | $103.92M | $1.85M |
| Investing cash flow | -$86.17M | -$50.82M | -$87.35M | -$24.29M | -$11.38M |
| Financing cash flow | -$37.11M | $20.38M | -$15.79M | -$98.83M | -$8.48M |
| Depreciation & amortization | $28.20M | $26.93M | $24.58M | $20.51M | $18.29M |
| Stock-based compensation | $4.21M | $4.52M | $4.39M | $3.56M | $3.56M |
| Dividends paid | $46.76M | $24.40M | $34.80M | $54.93M | $34.53M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.